Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

Recruiting now

Conditions studied: Cytomegalovirus Infections

In brief

The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center. Participants will complete a health survey and provide one saliva sample for CMV PCR testing. In addition, infrastructure for the study will be developed (e.g. community engagement to build the network of centers, data pipelines, digital platform, sampling workflows) and participant sample collection at home will be piloted. These activities will inform the design of STAGE II.

Key facts

Study ID
NCT06522880
Run by
University of Massachusetts, Worcester
People needed
100
Starts
2023-08-10
Expected to finish
2027-12-31
Last updated by the study team
2024-07-26

Who can join

Age: 0 and older, up to 3. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.